SSKN — STRATA Skin Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $1.00m
- $8.44m
- $30.70m
Annual cashflow statement for STRATA Skin Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.71 | -5.55 | -10.8 | -10.1 | -6.26 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.142 | 2.18 | 4.95 | 4.8 | 0.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.324 | -2.88 | -0.069 | 0.688 | -0.886 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.51 | -0.924 | -0.519 | 0.188 | -2.79 |
| Capital Expenditures | -3.65 | -3.74 | -5.02 | -1.64 | -1.47 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3.47 | -0.631 | 0 | — | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | -7.13 | -4.37 | -5.02 | -1.64 | -1.47 |
| Financing Cash Flow Items | -0.133 | -0.5 | -0.139 | -0.018 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.092 | -0.5 | 6.86 | 1.93 | 3.58 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.53 | -5.79 | 1.32 | 0.477 | -0.683 |